SpartanNash Company (SPTN) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
14 Aug, 2025Executive summary
Net sales rose 1.8% year-over-year to $2.27 billion in Q2 2025, with Retail segment up 12.8% and Wholesale down 3.0%, driven by acquisitions offsetting lower Wholesale volumes.
Net earnings were $6.2 million ($0.18 per diluted share), down from $11.5 million ($0.34 per share) in Q2 2024, mainly due to merger costs and higher non-cash expenses.
Adjusted EPS was $0.54, compared to $0.59 in the prior year quarter.
Adjusted EBITDA increased to $68.7 million from $64.5 million year-over-year.
Entered a Merger Agreement with C&S Wholesale Grocers for $26.90 per share, totaling $1.77 billion, a 52.5% premium, expected to close in late 2025.
Financial highlights
Gross profit margin improved to 16.8% from 15.8% year-over-year, driven by higher Retail mix and improved Wholesale margin.
Cash from operating activities was $112.6 million for the first half, down from $132.1 million year-over-year.
Capital expenditures and IT capital totaled $56.2 million in H1 2025, down from $73.4 million in H1 2024.
$15.5 million returned to shareholders via dividends in H1 2025.
Retail segment net sales up 12.8% to $762.9 million; Wholesale segment net sales down 3.0% to $1.51 billion.
Outlook and guidance
Anticipates unfavorable Wholesale sales impact due to a major customer transitioning to in-sourcing.
Expects continued capital and operating investments to support growth and cost-saving initiatives.
Macroeconomic headwinds, including input cost inflation and changing consumer demand, may pressure future results.
Latest events from SpartanNash Company
- Q2 net sales declined 3.5% and adjusted EPS was $0.59; 2024 guidance reaffirmed.SPTN
Q2 20241 Feb 2026 - Q3 sales dipped 0.6% as cash flow rose and acquisitions support future EBITDA growth.SPTN
Q3 202415 Jan 2026 - Record adjusted EBITDA, strong cash flow, and 2025 growth outlook despite Q4 impairment.SPTN
Q4 202423 Dec 2025 - Sales up 3.7% to $2.91B, record adjusted EBITDA, but net earnings fell on higher costs.SPTN
Q1 202526 Nov 2025